| pubmed-article:21458098 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C0389071 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C0948265 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C1179435 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C0021655 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C1829779 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C1705248 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C1882141 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C1548799 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C1524073 | lld:lifeskim |
| pubmed-article:21458098 | lifeskim:mentions | umls-concept:C0449432 | lld:lifeskim |
| pubmed-article:21458098 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:21458098 | pubmed:dateCreated | 2011-6-7 | lld:pubmed |
| pubmed-article:21458098 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21458098 | pubmed:abstractText | We evaluated the ratio of adiponectin level to homeostasis model assessment of insulin resistance (A/H ratio) as a risk marker for metabolic syndrome (MetS) and each of its components. The A/H ratio may prove to be a powerful index for evaluation of risk for MetS and each of its components. | lld:pubmed |
| pubmed-article:21458098 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21458098 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21458098 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21458098 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21458098 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21458098 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21458098 | pubmed:issn | 1872-8227 | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:HondaHiroyuki... | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:NaruseKeikoK | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:IzawaHideoH | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:YokotaMitsuhi... | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:MatsubaraTats... | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:KatoRyujiR | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:IchiharaSahok... | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:MuraseYosukeY | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:AsanoHiroyuki... | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:MiyataSeikoS | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:NakatochiMasa... | lld:pubmed |
| pubmed-article:21458098 | pubmed:author | pubmed-author:TanimuraDaisu... | lld:pubmed |
| pubmed-article:21458098 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Ireland Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:21458098 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21458098 | pubmed:volume | 92 | lld:pubmed |
| pubmed-article:21458098 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21458098 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21458098 | pubmed:pagination | e61-5 | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:meshHeading | pubmed-meshheading:21458098... | lld:pubmed |
| pubmed-article:21458098 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21458098 | pubmed:articleTitle | The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study. | lld:pubmed |
| pubmed-article:21458098 | pubmed:affiliation | Department of Biotechnology, Nagoya University School of Engineering, Nagoya, Japan. | lld:pubmed |
| pubmed-article:21458098 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21458098 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
